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Highlights
●  A new benzofuran derived compound inhibits T. cruzi epimastigotes growth.
●  The compound has an antiproliferative effect on T. cruzi amastigotes in host cells.
● The drug releases Ca2+ from intracellular compartments from this parasite.
● The compound dissipates the mitochondrial electrochemical membrane potential  from 
T. cruzi
● The drug induces the alkalinization of the acidocalcisomes from this parasite
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Graphical Abstract
Abstract
Chagas disease is a neglected tropical affection caused by the protozoan parasite 
Trypanosoma cruzi. There is no current effective treatment since the only two available drugs 
have a limited efficacy and produce side effects. Thus, investigation efforts have been directed 
to the identification of new drug leads. In this context, Ca2+ regulating mechanisms have been 
postulated as targets for antiparasitic compounds, since they present paramount differences 
when compared to host cells. Amiodarone is an antiarrhythmic with demonstrated trypanocidal 
activity acting through the disruption of the parasite intracellular Ca2+ homeostasis. We now 
report the effect of a benzofuran derivative based on the structure of amiodarone on T. cruzi. 
This derivative was able to inhibit the growth of epimastigotes in culture and of amastigotes 
inside infected cells, the clinically relevant phase. We also show that this compound, similarly 
to amiodarone, disrupts Ca2+ homeostasis in T. cruzi epimastigotes, via two organelles 
involved in the intracellular Ca2+ regulation and the bioenergetics of the parasite. We 
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demonstrate that the benzofuran derivative was able to totally collapse the membrane potential 
of the unique giant mitochondrion of the parasite and simultaneously produced the 
alkalinization of the acidocalcisomes. Both effects are evidenced by a large increase in the 
intracellular Ca2+ concentration of T. cruzi.
1. Introduction 
Chagas’ disease, caused by the protozoan parasite Trypanosoma cruzi, is the most 
important parasitic disease in the western hemisphere (Bern, 2015). It affects millions of 
people around the world, prevailing in endemic areas of 21 Latin-American countries in which 
economic and medical support are limited (Rueda et al., 2014). Despite the efforts to eradicate 
vector transmission carried out by blood sucking triatomine bugs in most endemic areas, and 
the implementation of programs to prevent blood transfusion and congenital transmission 
respectively (Sosa-Estani and Segura, 2015), the disease remains a large problem owed to 
occurrence of oral infection outbreaks due to consumption of triatomine-feces-contaminated 
food (Shikanai-Yasuda and Carvalho, 2012) and migration of affected people to non-endemic 
countries representing a risk factor (Schmunis, 2007). According to OMS, estimates indicate 
56.000 new cases and 12.000 deaths per year. The only treatment available is based on 
chemotherapy using the nitroaromatic compounds nifurtimox and benznidazole, which are 
inefficient especially in the chronic patients (Soeiro and de Castro, 2009), and present adverse 
side effects whereby its administration is limited (Prata, 2001). In fact a clinical study of 
benzidazol (BENEFIT) showed that although this compound decreases the parasitemia in 
humans, it does not improve the cardiomyopathy associated with the disease (Morillo et al., 
2015). For these reasons, in the last decades many efforts in infectious diseases research are 
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directed to the development of new drug leads and the determination of targets in T. cruzi for 
the treatment of the American trypanosomiasis (Duschak, 2011).
Since the 70’s many compounds carrying benzofuran in their structure, as well as 
multiple derivatives of this chemical group, have shown an effect against many trypansomatid 
species (Bakunov et al., 2009, 2008; Bakunova et al., 2007; Dann et al., 1973, 1972). Another 
very important compound initially designed and prescribed as an antiarrhythmic which 
possesses a benzofuran motif in its structure is amiodarone. Analogues derived from 
amiodarone had previously shown an inhibitory effect on T. cruzi (Kinnamon et al., 1998). The 
direct effect of amiodarone as an antitrypanosomatid drug was reported for the first time on T. 
cruzi, on which amiodarone has a potent synergism with posaconazol (Benaim et al., 2006). 
Later it was shown to be efficient also against Leishmania Mexicana (Serrano-Martín et al., 
2009a) acting synergistically with miltefosine (Serrano-Martín et al., 2009b). Dronedarone, 
synthesized as an amiodarone analogue with an improved safety profile, since it lacks iodine in 
its structure being the responsible for undesired effects of amiodarone, was also proved to be 
an efficient agent against T. cruzi (Benaim et al., 2012) and L. mexicana (Benaim et al., 2014). 
Furthermore in these reports, it was shown that both compounds, amiodarone and 
dronedarone, had several mechanisms of action in these parasites. First of all, both 
benzofuran derivatives inhibited the ergosterol biosynthesis. This inhibition is lethal for 
trypanosomatids, because they possess this sterol as an essential component of their 
membranes, instead of cholesterol which is present in humans.  On the other hand, both 
compounds disrupted Ca2+ homeostasis in trypanosomatids driving to a large increase in the 
intracellular Ca2+ concentration ([Ca2+]i). Interestingly, the increase in the [Ca2+]i was due at 
least by two organelles involved in the regulation of the cytoplasmic concentration of this cation 
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(Benaim and Garcia, 2011). One of them, the giant unique mitochondrion, in which the 
electrochemical potential was dissipated, leading to the release of accumulated Ca2+, since the 
electrochemical membrane potential is the driving force for the large Ca2+ buildup observed in 
this organelle (Benaim et al., 1990). Finally, both benzofuran derivatives showed a potent 
effect on the acidocalcisomes, essential organelles involved in the bioenergetic of these 
parasites, since they accumulate large amounts of calcium, polyphosphates and 
pyrophosphate, the last being an energy source alternative to ATP in trypanosomatids, 
besides being involved in the parasite Ca2+ homeostasis and osmoregulation (Docampo et al., 
1995).
We have reported previously the synthesis of a series of benzofuran derivatives inspired 
by the structure of amiodarone, from which two derivatives showed antifungal activity on 
Cryptococcus neoformans.  One of such compounds (denominated 4 in this previous report) 
was able to completely arrest C. neoformans growth at a concentration of 20 µM, while it 
affected human leukemia K-562 cells only at concentrations higher than 30 µM. Interestingly, 
this drug was able to enhance the Ca2+ mobilization produced by amiodarone in yeast 
(Hejchman et al., 2012).
In this work we report a new effect for the last mentioned benzofuran derivative 
(AMIODER), demonstrating that this compound has an inhibitory effect on T. cruzi and that this 
effect is partly related to the disruption of intracellular Ca2+ homeostasis in the parasite.
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Fig. 1. Chemical structure of (A) the benzofuran derivative (AMIODER), based on the structure 
of (B) amiodarone, used in this work (Hejchman et al., 2012).
2. Materials and Methods
2.1.Chemicals. The compound AMIODER (methyl 7-acetyl-5-bromo-6-hydroxy-3-
bromomethyl-2-benzofurancarboxylate) used in this work was provided by Dr. Elżbieta 
Hejchman from the Medical University of Warsaw.
2.2.  Mammalian host cell susceptibility to AMIODER. Vero cells (kidney epithelial cells from 
African green monkey) were employed as model mammalian host cells and were maintained in 
DMEM (Dulbecco’s Modified Eagle Medium), supplemented with 10 % fetal bovine serum at 
37 °C, 95 % air-5 % CO2. For cell viability determinations, Vero cells were cultured in a 96 well 
plate and exposed to different concentrations of AMIODER for 96 hours. Afterwards cells were 
washed with phosphate-buffered saline and MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
Diphenyltetrazolium Bromide) at 0.5 mg/mL was added followed by a period of incubation 
(4 hours). The resulting formazan produced by viable cells mitochondrial dehydrogenase 
activity was determined spectrophotometrically and the IC50 was determined using GraphPrism 
5.0.
2.3.Trypanosoma cruzi epimastigotes culture and susceptibility to AMIODER. T. cruzi 
epimastigotes (CL Brener strain) were grown in LIT (liver infusion tryptose) medium, pH 7.4, 
supplemented with 10% fetal bovine serum  at 29 °C and constant agitation as reported 
previously (Benaim et al., 2006). For drug susceptibility determinations the parasites were 
cultured in medium with different drug concentrations. Epimastigotes were placed in glass 
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tubes at an initial title of 6x106 parasites/mL and treated with increasing concentrations of 
AMIODER (0-50 µM), including a control with drug vehicle [dimethyl sulfoxide (DMSO)]. The 
number of parasites in culture was determined daily by direct counting in a Neubauer chamber. 
At least 3 independent experiments were performed for each condition and the 50 % inhibitory 
concentration was determined by using Prisma Graph Pad 5.0.
2.4.Determination of the effect of AMIODER on the cells infected with T. cruzi 
amastigotes. 
Amastigotes were cultured in Vero cells. For amastigote susceptibility assays, as reported 
previously (Benaim et al., 2012), Vero cells were cultured on plastic coverslips placed inside 
24 well plates, infected for 5 hours with tissue culture-derived trypomastigotes at a rate of 10 
parasites per host cell and then washed 3 times with phosphate-buffered saline (PBS) to 
remove non-adherent parasites. Medium with different drug concentrations (ranging from 0 to 
10 µM) was added and cells were incubated for 72 h. Coverslips with cells were washed with 
PBS and then stained with Giemsa. The percentage of infected cells was determined directly 
using a light microscopy. Statistical analysis was carried out and the 50 % inhibitory 
concentration was estimated using Prisma Graph Pad 5.0.
2.5. Determination of the intracellular Ca2+ concentration in T. cruzi epimastigotes.
T. cruzi epimastigotes were loaded with the Ca2+ radiometric indicator Fura 2 as reported 
previously (Benaim et al., 2014). The fluorophore Fura 2 is excited by two different 
wavelengths, 340 nm when it is Ca2+-bound, and 380 nm when it is free of Ca2+, and emission 
is recorded at a unique wavelength of 510 nm. For this reason, a spectrofluorimeter with the 
capacity to measure fluorescence ratios at two different wavelengths should be used. Briefly, 1 
× 107 parasites were collected by centrifugation at 600 x g for 2 minutes and washed twice in a 
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“loading buffer” (137 mM NaCl, 4 mM KCl, 1.5 mM KH2PO4, 8.5 mM Na2HPO4, 11 mM 
glucose, 1.8 mM CaCl2, 0.8 mM MgSO4, 20 mM HEPES-NaOH [pH 7.4]). The pellet was 
resuspended in 1 µM of Fura 2-AM (the permeable acetoxymethylester derivative of FURA 2). 
Probenecid (2.4 mM) and pluronic acid (0.05%) were added to the loading buffer. The 
parasites were incubated at 29 °C in the dark with continuous agitation for 2 hours. Fura 2-AM-
loaded parasites were washed twice in the same buffer, in either the presence or absence of 
Ca2+. Additionally, the chelating agent ethylene glycol tetraacetic acid (EGTA) was added at 
500 µM when measurements were made in the absence of extracellular Ca2+. Fluorescence 
measurements were carried out on a stirred cuvette at 29 °C, using a Perkin-Elmer 
spectrofluorimeter LS-55 with a double wavelength excitation beam (340 nm and 380 nm) and 
recording the emission at 510 nm.  
2.6. Mitochondrial membrane potential determinations.
The effect of the drug on the mitochondrial membrane potential of T. cruzi epimastigotes 
was evaluated using the fluorescent dye rhodamine 123 as reported previously (Benaim et al., 
2006), taking advantage of the internationalization of this fluorophore, according to the 
mitochondrial electrochemical membrane potential (Δφ). Briefly, 8 × 106 parasites were 
collected by centrifugation at 600 x g for 2.5 min and washed in phosphate-buffered saline 
(PBS) plus 1% glucose. The pellet was resuspended in the same buffer in the presence of 
rhodamine 123 (20 µM) and incubated for 45 min at 29 °C in the dark with continuous stirring. 
Subsequently, parasites were washed twice and resuspended in the same buffer, and then 
transferred to a stirred cuvette. Measurements (excitation wavelength [ʎext], 488 nm; emission 
wavelength [ʎem], 530 nm) were made in a Hitachi 7000 spectrofluorimeter at 29 °C. The 
protonophore FCCP (2 µM) was used as a positive control.  
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2.7.  Determination of acidocalcisomes alkalinization. 
The effect of the benzofuran compound on acidocalcisomes was evaluated using acridine 
orange, which accumulates in acidic compartments (Benaim et al., 2014). Epimastigotes 
(8×106 cells/mL) were collected, washed and incubated in a “loading buffer” (the same used in 
mitochondrial membrane potential measurements) with acridine orange at 2 µM for 5 min at 29 
°C in the dark and with constant stirring. Measurements were performed with ʎext at 488 nm 
and ʎem at 530 nm at 29°C in a Hitachi 7000 spectrofluorimeter under magnetic stirring. 
Nigericin, a monovalent ionophore acting as a K⁺/H⁺ exchanger, was used at 2 µM as a 
positive control.
3. Results and discussion
First we determined the antiproliferative effect of AMIODER on T. cruzi epimastigotes 
grown in axenic medium.  As can be seen in Fig. 1, AMIODER showed a dose-dependent 
inhibitory effect on parasites growth. The calculated IC50 was 8,5 µM. A total growth arrest at 
30 µM of the benzofuran derivative can also be observed. 
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Fig. 2. Susceptibility of Trypanosoma cruzi epimastigotes to AMIODER. Cultures of T. 
cruzi epimastigotes were grown in the presence of different concentrations of AMIODER. 
Experiments were carried out in triplicate and each bar represents the standard deviation of 
the experimental points.
We then evaluated the effect of AMIODER on cells infected with T. cruzi amastigotes 
which is the clinically relevant stage of the parasite. For this purpose, Vero cells, a classical 
and very efficient cell line model frequently used to study T. cruzi amastigotes infectivity 
(Benaim et al., 2006),  were incubated with T. cruzi trypomastigotes, treated with different 
concentrations of AMIODER for 96 hours, and then the number of cells infected with 
intracellular amastigotes was determined. As shown in Fig. 3, AMIODER had a clear dose-
dependent effect against intracellular amastigotes, diminishing the total percentage of infected 
cells. The calculated IC50 was 1.0 µM.  We then determine the effect of the drug on Vero cells, 
by using the MTT assay, obtaining an IC50 value of 39.5 µM and thus, a relatively low cytotoxic 
effect on these cells (Fig. 4). The calculated Selectivity Index (SI) for this drug determined by 
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the ratio of the IC50 of Vero cells over the IC50 obtained for amastigotes was 39.5, indicating a 
nearly 40 times more selective cytotoxicity on the clinically relevant amastigote form, when 
compared with the host cell. Taking in consideration the definition described by Katsuno et al, 
2015, in which a SI higher of 10 is considered a significant value, it could be considered that 
this compound possesses a relatively high selectivity index (Katsuno et al., 2015). 
Fig. 3. Effect of AMIODER against intracellular amastigotes of T. cruzi. Vero cells were 
infected with T. cruzi trypomastigotes and then treated with different concentrations of the 
benzofuran derivative. The percentage of infected cells (squares) and the IC50 on amastigotes 
were determined 96 h post-treatment. Experiments were carried out in triplicate and each bar 
represents the standard deviation of the experimental points.
ACCEPTED MANUSCRIPT
12
Fig. 4. Effect of AMIODER on Vero cells viability. Cells were exposed to different 
concentrations of AMIODER and cytotoxicity was measured by the MTT assay. Data points 
(Cell viability percentage per concentration) and bars represent the arithmetic mean ± SD 
(N=3). The IC50 after 96 hours of treatment is shown.
A comparative analysis on the biological activity of other benzofuran derivatives against 
T. cruzi, reveals that it has been reported that extracts from the Brazilian plant Piper regnelli 
var. pallescens have an antiprotozoal effect. Four of such isolated compounds, namely, 
eupomatenoid-3, eupomatenoid-5, epupomatenoid-6 and conocarpan showed antiproliferative 
activity on epimastigotes of T. cruzi with IC50 values of 90, 23.8, 28.4 and 30 µM, respectively. 
Interestingly, eupomatenoid-5 showed higher anti-T. cruzi activity than the reference drug 
benznidazol, causing a 100% inhibition of parasite growth at a concentration of 34 µM, 
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compared to benznidazole which only produced 78 % of inhibition at 38 µM. Furthermore, 
eupomatenoid-5 showed a relatively safe chemotherapeutic profile not producing hemolytic 
effect and a IC50 of 849 µM on Vero cells (Luize et al., 2006b). Similar reports, emphasize the 
study of eupomatenoid-5 on T. cruzi, showing that this compound also inhibits the proliferation 
of the clinically relevant form, amastigotes inside LLCMK2 cells, with an IC50 of 17 µM. 
Additionally, it was observed through electron microscopy, that at the IC50, this compound was 
able to induce morphological alterations in both epimastigotes and intracellular amastigotes 
without affecting host cells, causing massive alterations of the cell membrane, the formation of 
autophagic vacuoles and mitochondrial swelling, as well as an effect on the kinetoplast 
integrity  (Luize et al., 2006a). The same group makes a further evaluation of eupomatenoid-5 
on T. cruzi, reporting that this compound also affects the trypomastigote stage with an IC50 of 
40.5 µM and showing that the effects produced on these form are similar to the alterations 
observed on epimastigotes and amastigotes. A deeper study on the possible mechanism used 
by this bezofuran derivative showed that, after 24 h of treatment, it induces oxidative stress in 
both epimastigotes and trypomastigotes, increasing lipid peroxidation, as well as an increase 
in the production of NADPH+ and on the level of consumption of H2O2 by increasing the activity 
of glucose-6-phosphate (G6PD) and 6-phosphogluconate dehydrogenases (6PGD), enzymes 
belonging to the pentose phosphate pathway, key in the defense against oxidative stress. 
When parasites were treated for 96 h with eupomatenoid-5, the activity of both enzymes and 
the concentration of NADPH+ diminished, meaning that the cell damage caused by the 
treatment, rendered the parasites unable to be defended against oxidative stress (Pelizzaro-
Rocha et al., 2011). Another group of active compounds derived from benzofuran have been 
studied by Ameta et al, 2012, reporting the synthesis of a series of 2- (substituted 
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benzylidene)-5,7-dibromo-6-hydroxy-1-benzofuran-3 (2H)-ones and the evaluation of these 
compounds on T. cruzi amastigotes inside Vero cells. The most effective compounds were 2b 
and 2k with an IC50 of 19.4 and 10.7 µM, respectively. Additionally, the IC50 on LLCMK2 for 2b 
and 2k were 58 and 78 µM, respectively, meaning that these derivatives have a relatively good 
selectivity index, and thus, constitute prospective drug leads for further studies (Ameta et al., 
2012). As mentioned before, amiodarone, a benzofuranic compound known for its 
antiarrhythmic properties, has shown to possess a marked effect against T. cruzi 
epimastigotes and amastigotes in vitro with IC50 values of 9 and 2.7 µM, respectively. 
Interestingly, amiodarone had a synergistic activity with the well known antifungal drug 
posaconazole and showed efficiency in vivo on a murine model of Chagas disease, increasing 
mice survival when both drugs were used in combination (Benaim et al., 2006). Similar results 
were obtained by the use of dronedarone, showing IC50 values of 4.6 and 0.75 µM against 
epimastigotes and amastigotes respectively (Benaim et al., 2012). 
Next we intended to elucidate the possible mechanism of action of AMIODER on T. 
cruzi parasites. Taking in consideration that amiodarone exerts its action on these parasite 
through the disruption of Ca2+ homeostasis we tested the effect of AMIODER on the [Ca2+]i. 
For this purpose, epimastigotes were loaded with the fluorimetric Ca2+ indicator Fura 2 and 
then exposed to AMIODER, while performing real time fluorescence measurements in a 
double wavelength fluorimeter, measuring the emission at 510, while exciting at the ratio of 
340 and 380 nm. Fig. 5 shows the effect of AMIODER on the [Ca2+]i in T. cruzi epimastigotes. 
It can be observed a large increase in the [Ca2+]i upon addition of the drug (10 µM). In order to 
determine if the large increase in the Ca2+ concentration was due to the entrance of Ca2+ from 
the outside milieu or instead, from its release from intracellular compartments, we performed 
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the same experiment but in the absence of extracellular Ca2+ (EGTA). Interestingly, this 
cytoplasmic Ca2+ concentration increase was very similar both in presence (Fig. 5A) and 
absence of extracellular Ca2+ (Fig. 5B), indicating that the cation is released from intracellular 
compartments, possibly the unique giant mitochondrion and the acidocalcisomes. 
Fig 5. Effects of AMIODER on intracellular Ca²⁺ concentration of T. cruzi epimastigotes. 
(A) Effect of AMIODER at 10 µM (arrow) on the intracellular Ca2+ concentration of T. cruzi 
epimastigotes in the presence of 2 mM of extracellular Ca2+. (B) Effect of AMIODER (10 µM) 
on the intracellular Ca2+ concentration of T. cruzi epimastigotes in the absence of extracellular 
Ca2+.
Next we intended to elucidate the possible role of these two intracellular organelles in 
the observed [Ca2+]i increase generated by AMIODER, taking in consideration that both 
compartments  act as intracellular Ca2+ reservoirs and also based on previous reports showing 
the disrupting effect on both organelles by other benzofuran derivatives, like amiodarone and 
dronedarone on T. cruzi (Benaim et al., 2012, 2006) and L. mexicana (Benaim et al., 2014; 
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Serrano-Martín et al., 2009a). First, we evaluated the effect of AMIODER on the mitochondrial 
membrane potential of T. cruzi epimastigotes by loading the parasites with the fluorescent dye 
rhodamine 123 which is known to accumulate in the energized mitochondria according to the 
electrochemical membrane potential (ΔΨm). Concerning the rationale of these experiments, it 
is well known that trypanosomatids are able to accumulate large amounts of Ca2+ into their 
giant unique mitochondrion by mean of a CMU that uses the H+ electrochemical potential as a 
driving force for Ca2+ accumulation. This CMU is very well conserved among species, being 
present from humans to all trypanosomatids so far studied (Benaim et al., 1990; Docampo and 
Vercesi, 1989). As a consequence of this Ca2+ transport mechanism the cation accumulates in 
large quantities inside the organelle and it is released as a product of its deenergization. Fig. 
6A, shows a large increase in the fluorescence upon addition of AMIODER, which is 
interpreted as the dissipation of ΔΨm and subsequent release of the mitochondrion-
accumulated rhodamine 123. After addition of the benzofuran derivative, FCCP, a potent 
known protonophore and oxidative phosphorylation uncoupler, was added as a positive control 
and a further increase in fluorescence was observed due to the complete disruption of the 
ΔΨm. In Fig. 6B, it can be observed the results of the same experiment, but inverting the order 
of addition of the effectors. As expected, the addition of FCCP produced a large and fast 
increase in the fluorescence of rhodamine 123. Nevertheless, the subsequent addition of 
AMIODER was still able to induce a further effect, though small. This could be explained if, 
under the experimental conditions used in these experiments, FCCP did not have full access 
to the mitochondrion and therefore could not produce the total dissipation of the ΔΨm.
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Fig 6. Effect of AMIODER on the mitochondrial electrochemical potential (ΔΨm) of T. 
cruzi epimastigotes. (A) AMIODER (10 µM) was added (arrow) to the parasites previously 
loaded with rhodamine 123, followed by the addition of FCCP (2 µM). (B) FCCP (2 µM) was 
added (arrow) followed by AMIODER (10 µM). (C) Percentage of rhodamine 123 fluorescence 
increase with respect to the basal level after addition of different concentrations of AMIODER 
to T. cruzi epimastigotes. Bars represent the mean ± SD of three independent experiments.
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Several studies carried out on T. cruzi have shown other benzofuranic compounds 
targeting related mechanisms to the ones studied in this work. Like AMIODER, amiodarone 
was able to dissipate the mitochondrial membrane potential and alkalinize the acidocalcisomes 
with a concomitant increase in the cytoplasmic Ca2+ concentration in the parasites, without 
affecting host cells as seen by fluorescence microscopy. Interestingly, amiodarone was found 
to target ergosterol biosynthesis in T. cruzi epimastigotes, acting as an oxidosqualene cyclase 
inhibitor (Benaim et al., 2006). Similar mechanisms of action were observed by the use of the 
amiodarone analog, dronedarone, on T. cruzi. Thus, when epimastigotes were treated with a 
concentration equal to IC50, dronedarone was able to dissipate the mitochondrial membrane 
potential and alkalinize the acidocalcisomes (Benaim et al., 2012). More extensive studies on 
the mechanisms involved in the trypanocidal action of eupomatenoid-5 have shown a marked 
involvement of the mitochondria in triggering a series of cell death events in T. cruzi after 
exposure to this compound. It was shown that eupomatenoid-5 induces an oxidative stress in 
the three main forms of the parasite, dissipating the mitochondrial membrane potential, 
increasing the concentration of reactive oxygen and nitrogen species through the damage of 
electron transport chain in mitochondria, due to a decreased trypanothione reductase activity. 
This oxidative injure leads to an apoptotic, autophagic and necrotic cell death in T. cruzi 
(Lazarin-Bidóia et al., 2013). 
After the study of the mode of action of these benzofuran derivatives on T. cruzi, it can 
be strongly suggested that Ca2+ homeostasis could be considered as a common target for 
these parasites, mainly through the disruption of organelles acting as Ca2+ reservoirs. One of 
such, the mitochondrion, is directly associated with Ca2+ regulation, and a brake in its 
equilibrium, either through an uncoupling in redox metabolism or the dissipation of the 
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mitochondrial membrane potential, produces an alteration in the intracellular Ca2+ 
homeostasis, triggering a signaling cascade which would drive to parasite death (Benaim and 
Garcia, 2011).
Acidocalcisomes are acidic organelles present in trypanosomatids postulated to be 
involved in osmoregulation and on the bioenergetics of these parasites (Docampo and 
Moreno, 2011). This organelle accumulates large quantities of polyphosphate and PPi. This 
later is considered as an energy source alternative to ATP in trypanosomatids. 
Acidocalcisomes are also very important as a Ca2+-accumulating compartments, possessing a 
variety of transport mechanisms, including a vacuolar type H+-ATPase, a Ca2+/H+ 
countertransporting ATPase for Ca2+ uptake, a Ca2+/H+ uniporter and a Na+/H+ antiporter 
involved in Ca2+ release (Docampo et al., 1995; Vercesi et al., 1994; Vercesi and Docampo, 
1996). We next determine whether the benzofuran derivative had an effect on the 
acidocalcisomes of T. cruzi epimastigotes, taking in consideration that other benzofuran 
derivatives as amiodarone and dronedarone directly affect these important organelles (Benaim 
et al., 2014, 2012; Benaim and Paniz Mondolfi, 2012). With this purpose, parasites were 
loaded with the fluorescent dye acridine orange, which is known to accumulate in acidic 
compartments as acidocalcisomes (Benaim et al., 2012). Upon addition of the drug, while 
measuring changes in fluorescence, it can be observed (Fig. 7A) a large increase in the 
fluorescence of acridine orange after addition of AMIODER (10 µM), consequence of the 
release of the accumulated dye after the alkalinization of the organelle. The subsequent 
addition of nigericine, a monovalent cation exchanger known to induce the acidocalcisomes 
alkalinization after the release of H+ in exchange for cytosolic K+ (Vercesi and Docampo, 
1996), generates a further, but small, acridine orange release. Addition of nigericine after 20 
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µM AMIODER instead of 10 µM did not produce any further increase in fluorescence, 
indicating that at this concentration these organelles were already fully alkalinized. When the 
order of addition of both effectors was inverted (Fig. 7B), nigericine produced a rapid response, 
as expected. However, this was followed by a further increase in fluorescence, generated by 
the addition of AMIODER. This additional acridine orange release produced by the drug after 
nigericine suggests the existence of other acidic compartments on which the benzofuran 
derivative could also exert an effect (lisosomes, acidic vacuoles, etc). In Fig. 7C it can be 
observed a dose-dependent increase in acridine orange fluorescence increase with respect to 
the basal level after addition of different concentration of AMIODER to T. cruzi epimastigotes, 
showing that 20 µM produced the maximal effect.  Since the alkalinization of acidocalcisomes 
is associated with the release of Ca2+ from these reservoirs (Benaim and Garcia, 2011; 
Vercesi and Docampo, 1996), the data from this results explain the observed effect of 
AMIODER on the [Ca2+]i in T. cruzi observed in the absence of extracellular Ca2+ (Fig. 5B). This 
effect should be additive to that resulted from the release of Ca2+ from the mitochondrion (Fig 
6) by the action of the drug on the ΔΨm.
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Fig 7. Effects of AMIODER on the level of acidocalcisomes alkalinization in T. cruzi 
epimastigotes. (A) AMIODER at 10 µM was added (arrow) to the stirring cuvette carrying 
parasites loaded with acridine orange, followed by addition of nigericine (2 µM). (B) Addition of 
nigericine (2 µM) was followed by AMIODER (10 µM). (C) Percentage of acridine orange 
fluorescence increase with respect to the basal level after addition of different concentration of 
AMIODER to T. cruzi epimastigotes. Bars represent the mean ± SD of three independent 
experiments.
Taking together, in this work we demonstrate that AMIODER has inhibitory effect on the 
growth of T. cruzi epimastigotes. More importantly, this drug also has an effect against 
amastigotes inside host cells. the clinically relevant phase of these parasites,  with an IC50 
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even lower than that previously reported for this compound against C. neoformans (Hejchman 
et al., 2012), with a relatively low effect on mammal host cells. Interestingly, this benzofuran 
derivative disrupts the Ca2+ homeostasis in T. cruzi by affecting to essential organelles, the 
mitochondrion and the acidocalcisomes, both directly involved in the bioenergetic of this 
parasite. This results are in contrast to that reported for S. cereviciae on which this compound 
had no effect alone on Ca2+ homeostasis on yeast, but potentiates the activity of amiodarone 
in this respect (Hejchman et al., 2012). The trypanocidal activity of this compound, and its 
previously reported antifungal effect, place it as a new potential drug lead for further research 
on protozoan parasites and fungi, for the design of new compounds with enhanced biological 
activity.
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